Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE - Wikidata - awgldk - TriplyDB

Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE

Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE

http://www.wikidata.org/entity/Q37019629

about

Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination Disturbances of apoptotic cell clearance in systemic lupus erythematosus Linking innate and adaptive immunity: human Vgamma9Vdelta2 T cells enhance CD40 expression and HMGB-1 secretion High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies DAMPs from Cell Death to New Life Inflammatory etiopathogenesis of systemic lupus erythematosus: an update Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases Cell death and DAMPs in acute pancreatitis PAMPs and DAMPs: signal 0s that spur autophagy and immunity Cell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexes The translocation of nuclear molecules during inflammation and cell death Controversial role of toll-like receptors in acute pancreatitis How apoptotic cells aid in the removal of their own cold dead bodies DAMPs, MAMPs, and NAMPs in plant innate immunity Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus HMGB1 loves company The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens Enhanced efferocytosis by dendritic cells underlies memory T-cell expansion and susceptibility to autoimmune disease in CD300f-deficient mice Dangers within: DAMP responses to damage and cell death in kidney disease.The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1.Alarmins: awaiting a clinical response Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signaling Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus.Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-α and TNF-α in systemic lupus erythematosus.Several nuclear events during apoptosis depend on caspase-3 activation but do not constitute a common pathway.Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.Pathogenesis of human systemic lupus erythematosus: recent advances.Association between high mobility group box‑1 protein expression and cell death in acute pancreatitis Circulating tumor cells promote the metastatic colonization of disseminated carcinoma cells by inducing systemic inflammation Pathogenic mechanisms in systemic lupus erythematosus.Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome.Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.Stepwise release of biologically active HMGB1 during HSV-2 infection.Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.

P2860

Q21131298-D2BA1338-1BE8-4DB3-808A-380B1D4D364D Q21195358-9A143CF2-BC23-4084-865B-19A3D343C790 Q24309154-57FA4C38-2DAE-4820-8917-7251DC43B4CD Q24604370-0814AB75-A22A-4BA9-A984-153104DA4F86 Q26739959-15809E41-6BA5-472D-82B2-5EF34C464397 Q26748941-07445DA0-D4B3-47B6-A06C-E67CBFE966CD Q26768480-5ECFA3D0-7E77-421F-B1A6-83EE67FE3D81 Q26781215-FA7A7747-7BCF-4C6B-9AA9-B58C879020EA Q26782785-00530D6C-F8CD-4409-8E5F-4DA814AD9892 Q26796413-2F9C4DB9-9AE7-4141-872E-B3875A69D66B Q26823714-A47D70C7-0E40-4F6A-9E59-1A16CC62AB20 Q26829321-AFBFF0CD-E9C8-4F05-BEB3-036B64B5601C Q26994999-AD8B2FBF-F603-4182-A7F2-532C9A852B30 Q27004190-7B914634-DD14-466D-87DE-A27E09F2CF83 Q27008742-71655EC0-37E7-488C-B6C9-109D7501DDAD Q27010599-0E3DF2D0-CACE-494D-B589-B3933969AB5E Q27025519-C6CD0178-70C9-44DF-AE76-CF5F11FEC9B1 Q27026126-2378C1C0-9283-494D-BAFB-9A410EF5C8DE Q28066924-BB36DEDF-9244-4D09-8712-9A69B4CBB846 Q28080920-96BD4099-0E3D-491E-A2A6-61B268F82708 Q28243671-D803708E-6AD9-4062-A7F7-E685FD6CABD0 Q28384138-0DC151EB-069A-423B-8717-7458696C76B5 Q28388910-1E83D6D9-9114-42A9-8D9A-E4DB4CB208FA Q28588565-1E7F877E-0C88-4852-9375-7F14D74CFBED Q30380000-0C8D9D68-EC11-492E-B307-FC86EA4C89BD Q30505780-8DD5E2E4-27BD-4CF7-970E-1CEF47A84E67 Q30523797-99774159-ACB4-4774-B317-74D2902BF6AA Q30583559-25F80273-25CD-4AD7-9452-E982361D7751 Q33386391-D13B4E7F-6882-4161-A8A9-95FF100A3097 Q33393060-03A4767A-EFAE-4B68-B4A9-0F443DB8F4EF Q33488543-51CB46DF-268B-42E6-A3EC-DEFEC5787C1C Q33608479-29157C3E-699D-42FC-9DD9-B311177E75BD Q33664927-8269E89B-DA84-4170-AD8D-F0935CDF3A03 Q33702146-5FB900DC-FD7C-4043-840B-9B231976425F Q33709719-24C770A2-CA0C-4295-AE75-012994248A87 Q33715441-1004DC40-CCB0-4446-8376-C20E887849D2 Q33715480-0932AD9B-020E-4B06-BDCF-0F8EB4201783 Q33751106-4DF65E4D-DC57-4751-A714-5D11C8FC5DCF Q33809521-4673B1A0-AE49-4EB4-AD42-D9EE4AE11925 Q33814903-6205F9CA-3A46-4151-81D5-5AE37ACC5DE5

P2860

Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE

http://www.wikidata.org/entity/Q37019629

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Induction of inflammatory and ...... ns for the pathogenesis of SLE

@en

Induction of inflammatory and ...... s for the pathogenesis of SLE.

@nl

type

label

Induction of inflammatory and ...... ns for the pathogenesis of SLE

@en

Induction of inflammatory and ...... s for the pathogenesis of SLE.

@nl

prefLabel

Induction of inflammatory and ...... ns for the pathogenesis of SLE

@en

Induction of inflammatory and ...... s for the pathogenesis of SLE.

@nl

P1433

Q37019629-04CA4CB4-2BD7-4E46-BC7C-42AC64D3AA5A

P1476

Q37019629-B5B4D5A4-8656-4A4E-900C-78BE28725E73

P2093

Q37019629-092A456C-3670-4236-B323-DE2817785AF5

Q37019629-118151EF-2756-4930-8782-CB72A6139692

Q37019629-1CE537B0-08A4-4D4D-8FCE-35E0B7EC955C

Q37019629-3C72E60D-58EA-408A-97C6-7A154F8DBC01

Q37019629-AD5FB812-498F-4E0C-9C3C-6EA978F1EDF6

Q37019629-CCD489E6-5D21-431F-ABB0-F3AEDA596C65

Q37019629-CD582CB8-A598-4E40-9940-C2F615FE0F23

Q37019629-D251527D-F5C1-4400-8FAD-801DD651A33A

Q37019629-F51B5550-51FB-47D1-AEB7-596BE76D0223

P2860

Q37019629-01598D30-F09B-4850-AB06-C0C2207DD7D4

Q37019629-02889487-955D-4CDA-8425-A8E1554F749F

Q37019629-065227BD-ECD4-4C27-9035-EB3C7F56F8A0

Q37019629-0ADB987D-A928-417B-8F47-A69D8C3494EE

Q37019629-0D99C35D-BBAA-4789-85C4-95FF9C9ADA88

Q37019629-11E93AFA-5632-4F47-A24E-7593137527CF

Q37019629-1C75FD1B-40BE-457A-8DBD-88BE115B5907

Q37019629-209AB1C4-0AD1-4CC8-9B4B-2D9171388AD2

Q37019629-23B9F3E1-5B30-4382-BBAD-1E08839DF2E6

Q37019629-279E846C-60EB-4075-8735-3E3E11C5662A

P304

Q37019629-12A2D906-4694-45B9-8B69-ADCE53C433D8

P31

Q37019629-FDD25D74-531A-4C39-A219-179B453F86C0

P356

Q37019629-A8C5D9E5-05E1-437F-9B2D-35A651E12901

P407

Q37019629-B74301E4-5A9B-4B3A-AC8A-40937B0D43C2

P433

Q37019629-99C4C0B0-6936-4C42-B844-4B132C90C54A

P478

Q37019629-DD75E7F1-74DB-4319-B453-ABC37287E513

P50

Q37019629-43D547AC-7823-4A4E-B937-4900770A9CF8

Q37019629-50C6702F-56C6-4D2D-8AF5-6C71B48025D9

Q37019629-5C7B0DF2-8A44-48F4-B383-41E83B36B47E

Q37019629-C3C23260-223B-4E3E-9C2C-F5E07F7CB837

Q37019629-C7A7019E-0101-47A3-B29F-44C8B99F8518

Q37019629-F371FA03-8EAD-4D15-BDC4-3B673F2F900D

P577

Q37019629-0C267FCB-189C-42A7-ACB6-6ED63F0EED76

P5875

Q37019629-A59F6034-D2D7-492C-9884-C3907AAF4405

P698

Q37019629-9547F883-DAFF-4FD7-B5F0-482AE5C9F233

P921

Q37019629-A63D295E-9ECB-4045-9BE6-8C723D5289A2

Q37019629-EB7311CF-E66E-4136-A9DE-DAF762CA72DC

P932

Q37019629-49654C32-32DA-4BB2-9B92-FBDB290D5582

P356

P1433

Journal of Experimental Medicine

P1476

Induction of inflammatory and ...... ns for the pathogenesis of SLE

@en

P2093

Angelo A Manfredi

http://www.w3.org/2001/XMLSchema#string

Barbara G Fürnrohr

http://www.w3.org/2001/XMLSchema#string

Carsten Kirschning

http://www.w3.org/2001/XMLSchema#string

Hermann Wagner

http://www.w3.org/2001/XMLSchema#string

Joachim R Kalden

http://www.w3.org/2001/XMLSchema#string

Petra Heyder

http://www.w3.org/2001/XMLSchema#string

Reinhard E Voll

http://www.w3.org/2001/XMLSchema#string

Silke Meister

http://www.w3.org/2001/XMLSchema#string

Vilma Urbonaviciute

http://www.w3.org/2001/XMLSchema#string

P2860

A Toll-like receptor recognizes bacterial DNA

Cross-regulation of TNF and IFN-alpha in autoimmune diseases

Pathogenesis of systemic lupus erythematosus

Dendritic cells and the control of immunity

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

HMG-1 as a late mediator of endotoxin lethality in mice

Toll-like receptors in the induction of the innate immune response

DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis

HMG1 and 2, and related 'architectural' DNA-binding proteins

Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice

P304

3007-3018

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20081165

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

205

http://www.w3.org/2001/XMLSchema#string

P50

Marco E. Bianchi

Martin Herrmann

Patrizia Rovere-Querini

Francesco De Marchis

P577

2008-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23640082

http://www.w3.org/2001/XMLSchema#string

P698

19064698

http://www.w3.org/2001/XMLSchema#string

P921

P932

2605236

http://www.w3.org/2001/XMLSchema#string